# In-Office Clinical Study of the Solo+ TTD

> **NCT05741333** · NA · ACTIVE_NOT_RECRUITING · sponsor: **AventaMed DAC** · enrollment: 66 (estimated)

## Conditions studied

- Ear Infection
- Otitis Media

## Interventions

- **DEVICE:** Solo+ Tympanostomy Tube Device (Solo+ TTD)

## Key facts

- **NCT ID:** NCT05741333
- **Lead sponsor:** AventaMed DAC
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-03-30
- **Primary completion:** 2026-05
- **Final completion:** 2028-03
- **Target enrollment:** 66 (ESTIMATED)
- **Last updated:** 2026-04-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05741333

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05741333, "In-Office Clinical Study of the Solo+ TTD". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT05741333. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*